U.S. Cell and Gene Therapy CDMO Market is projected to grow from USD 2.09 Billion in 2025 to USD 10.28 Billion by 2035 due to expanding gene and cell therapy pipelines globallyAustin, March 06, 2026 ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

LiCellGrow was developed to assist therapy developers in determining the optimal culture conditions during process ...

A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s group, has published a new single-cell method called scHiCAR that ...

Research uncovering the origin of pineoblastoma, a rare pediatric brain tumor, has also revealed a dependency across multiple ...

Successful program buildout prioritizes defined patient flow, infusion access, cold-chain capabilities, and accountability ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...